Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
BMJ. 2023 Nov 16;383:e077848. doi: 10.1136/bmj-2023-077848.
To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk.
Systematic review and meta-analysis.
PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023.
Randomized controlled trials comparing intravascular imaging (intravascular ultrasonography or optical coherence tomography) guided versus coronary angiography guided percutaneous coronary intervention in adults with coronary artery disease.
Random effect meta-analysis and GRADE (grading of recommendations, assessment, development, and evaluation) were used to assess certainty of evidence. Data included rate ratios and absolute risks per 1000 people for cardiac death, myocardial infarction, stent thrombosis, target vessel revascularization, and target lesion revascularization. Absolute risk differences were estimated using SYNTAX risk categories for baseline risks at five years, assuming constant rate ratios across different cardiovascular risk thresholds.
In 20 randomized controlled trials (n=11 698), intravascular imaging guided percutaneous coronary intervention was associated with a reduced risk of cardiac death (rate ratio 0.53, 95% confidence interval 0.39 to 0.72), myocardial infarction (0.81, 0.68 to 0.97), stent thrombosis (0.44, 0.27 to 0.72), target vessel revascularization (0.74, 0.61 to 0.89), and target lesion revascularization (0.71, 0.59 to 0.86) but not all cause death (0.81, 0.64 to 1.02). Using SYNTAX risk categories, high certainty evidence showed that from low risk to high risk, intravascular imaging was likely associated with 23 to 64 fewer cardiac deaths, 15 to 19 fewer myocardial infarctions, 9 to 13 fewer stent thrombosis events, 28 to 38 fewer target vessel revascularization events, and 35 to 48 fewer target lesion revascularization events per 1000 people.
Compared with coronary angiography guided percutaneous coronary intervention, intravascular imaging guided percutaneous coronary intervention was associated with significantly reduced cardiac death and cardiovascular outcomes in patients with coronary artery disease. The estimated absolute effects of intravascular imaging guided percutaneous coronary intervention showed a proportional relation with baseline risk, driven by the severity and complexity of coronary artery disease.
PROSPERO CRD42023433568.
评估血管内成像指导与血管造影指导经皮冠状动脉介入治疗在冠状动脉疾病患者中的绝对治疗效果,同时考虑其基线风险。
系统评价和荟萃分析。
截至 2023 年 8 月 31 日,PubMed/Medline、Embase 和 Cochrane 图书馆数据库。
比较血管内成像(血管内超声或光相干断层扫描)指导与冠状动脉造影指导经皮冠状动脉介入治疗在冠状动脉疾病成人患者中的随机对照试验。
使用随机效应荟萃分析和 GRADE(推荐分级、评估、制定与评价)评估证据确定性。数据包括每 1000 人中的心脏死亡、心肌梗死、支架血栓形成、靶血管血运重建和靶病变血运重建的率比和绝对风险。使用 SYNTAX 风险分类估计 5 年内的基线风险的绝对风险差异,假设不同心血管风险阈值下的固定率比。
在 20 项随机对照试验(n=11698 人)中,血管内成像指导经皮冠状动脉介入治疗与心脏死亡风险降低相关(率比 0.53,95%置信区间 0.39 至 0.72)、心肌梗死(0.81,0.68 至 0.97)、支架血栓形成(0.44,0.27 至 0.72)、靶血管血运重建(0.74,0.61 至 0.89)和靶病变血运重建(0.71,0.59 至 0.86),但不包括全因死亡(0.81,0.64 至 1.02)。使用 SYNTAX 风险分类,高确定性证据表明,从低风险到高风险,血管内成像可能与每 1000 人中减少 23 至 64 例心脏死亡、15 至 19 例心肌梗死、9 至 13 例支架血栓形成事件、28 至 38 例靶血管血运重建事件以及 35 至 48 例靶病变血运重建事件相关。
与冠状动脉造影指导经皮冠状动脉介入治疗相比,血管内成像指导经皮冠状动脉介入治疗与冠状动脉疾病患者的心脏死亡和心血管结局显著降低相关。血管内成像指导经皮冠状动脉介入治疗的估计绝对效果与基线风险呈比例关系,这主要是由冠状动脉疾病的严重程度和复杂性驱动的。
PROSPERO CRD42023433568。